Redeveloping Drugs Based on Existing Patents
نویسندگان
چکیده
منابع مشابه
Competitive disadvantage through non–existing software patents
In a model of sequential patent races, it is examined whether or not introducing a patent law in the home country is beneficial to the firms and the society as a whole given the foreign country already offers patent protection. Before the first patent race starts, the firms and the foreign country share interests. For a given total number of firms, the welfare effect depends on the relative com...
متن کاملClassifying patents based on their semantic content
In this paper, we extend some usual techniques of classification resulting from a large-scale data-mining and network approach. This new technology, which in particular is designed to be suitable to big data, is used to construct an open consolidated database from raw data on 4 million patents taken from the US patent office from 1976 onward. To build the pattern network, not only do we look at...
متن کاملWhen Patents Fail: Finding New Drugs for the Developing World
Worldwide drug research budgets for diseases of poverty (e.g. malaria, African sleeping sickness) will likely double by 2010. The question is how best to spend this money. This paper analyzes the possible strategies in terms of two new categories. End-to-End (" E2E ") proposals try to mimic the patent system by using a single reward to elicit innovation throughout the entire drug discovery pipe...
متن کاملPatents Associated with High-Cost Drugs in Australia
Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by "evergreening" blockbuster drugs, through misuse of the patent system. There is, however, very little empirical information about this behaviour. We fill the gap by analysing all of the patents associated wi...
متن کاملPatents, Generic Drugs and the Markets for Antiretrovirals
After long years of negotiation, the Uruguay Round finally culminated in 1994 with the signing in Marrakesh of the controversial TRIPS (Trade-Related Aspects of Intellectual Property Rights) agreement, aimed at extending worldwide the type of intellectual property protection that had up until that point been granted to firms established in the most developed countries. All the while, the AIDS v...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Primary Health Care Open Access
سال: 2016
ISSN: 2167-1079
DOI: 10.4172/2167-1079.1000233